...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity
【24h】

Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity

机译:乳链菌肽与各种含细菌素肾上腺素的细胞壁前体的聚集体大小和膜渗透能力不同

获取原文
获取原文并翻译 | 示例

摘要

Many lantibiotics use the membrane bound cell wall precursor Lipid II as a specific target for killing Gram-positive bacteria. Binding of Lipid II usually impedes cell wall biosynthesis, however, some elongated lantibiotics such as nisin, use Lipid II also as a docking molecule for pore formation in bacterial membranes. Although the unique nisin pore formation can be analyzed in Lipid II-doped vesicles, mechanistic details remain elusive. We used optical sectioning microscopy to directly visualize the interaction of fluorescently labeled nisin with membranes of giant unilamellar vesicles containing Lipid II and its various bactoprenol precursors. We quantitatively analyzed the binding and permeation capacity of nisin when applied at nanomolar concentrations. Specific interactions with Lipid I, Lipid II and bactoprenol-diphosphate (C 55-PP), but not bactoprenol-phosphate (C55-P), resulted in the formation of large molecular aggregates. For Lipid II, we demonstrated the presence of both nisin and Lipid II in these aggregates. Membrane permeation induced by nisin was observed in the presence of Lipid I and Lipid II, but not in the presence of C55-PP. Notably, the size of the C 55-PP-nisin aggregates was significantly smaller than that of the aggregates formed with Lipid I and Lipid II. We conclude that the membrane permeation capacity of nisin is determined by the size of the bactoprenol-containing aggregates in the membrane. Notably, transmitted light images indicated that the formation of large aggregates led to a pinch-off of small vesicles, a mechanism, which probably limits the growth of aggregates and induces membrane leakage.
机译:许多羊毛硫抗生素使用膜结合的细胞壁前体脂质II作为杀死革兰氏阳性细菌的特定靶标。脂质II的结合通常会阻碍细胞壁的生物合成,但是,某些伸长的羊毛硫抗生素(如乳链菌肽)也将脂质II用作在细菌膜中形成孔的对接分子。尽管独特的乳链菌肽孔形成可以在脂质II掺杂的囊泡中进行分析,但机理细节仍然难以捉摸。我们使用光学切片显微镜直接可视化荧光标记的乳链菌肽与巨大的单层囊泡的膜之间的相互作用,该囊泡包含脂质II及其各种紫杉醇前体。我们定量分析了乳链菌肽在纳摩尔浓度下的结合和渗透能力。与脂质I,脂质II和二磷酸视紫红酚二酚(C 55-PP)的特异性相互作用,而不与二十碳五烯酚磷酸二酯(C55-P)特异性相互作用,导致形成大分子聚集体。对于脂质II,我们证明了这些聚集物中同时存在乳链菌肽和脂质II。在脂质I和脂质II存在下,但在C55-PP存在下,观察到由乳链菌肽诱导的膜渗透。值得注意的是,C 55-PP-乳链菌肽的聚集体的尺寸明显小于由脂质I和脂质II形成的聚集体的尺寸。我们得出结论,乳链菌肽的膜渗透能力取决于膜中含细菌素的聚集体的大小。值得注意的是,透射光图像表明大聚集体的形成导致小囊泡的夹断,这种机制可能限制聚集体的生长并引起膜泄漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号